Nigeria Set To Receive Revolutionary HIV Prevention Drug Lenacapavir

The National Agency for the Control of AIDS (NACA) has announced that Nigeria will soon receive Lenacapavir, a new HIV prevention drug that has demonstrated 100% effectiveness in clinical trials.

In a statement on Monday, Toyin Aderibigbe, NACA’s Head of Public Relations, confirmed that the agency has obtained regulatory approval from the National Agency for Food and Drug Administration and Control (NAFDAC) for the drug’s use.

Lenacapavir is administered via injection twice a year, offering a convenient alternative to daily oral HIV prevention medications.

Thanks to voluntary licensing agreements with generic manufacturers, the drug will be made available in Nigeria and 119 other low- and middle-income countries at an affordable price of $40 per person per year.

“The Government of Nigeria is advancing preparations for the introduction and rollout of Lenacapavir as Pre-Exposure Prophylaxis (PrEP). This is part of the government’s commitment to strengthen HIV prevention and accelerate progress toward epidemic control,” the statement read.